by Dylan Berman | Jun 22, 2026 | General
Definium Therapeutics Inc. (NASDAQ:DFTX) shares are surging Monday after the company announced positive topline results from its Phase 3 Emerge study evaluating DT120 orally disintegrating tablet in adults with major depressive disorder—with the trial meeting its...
by Piero Cingari | Jun 22, 2026 | General
The last week of June marks the tail of first-quarter earnings season, and it closes with the name most investors have been waiting for: Micron Technology, Inc. (NASDAQ:MU). The AI-memory giant has rallied 300% this year and crossed $1 trillion in market value, riding...
by Vandana Singh | Jun 22, 2026 | General
Regenxbio Inc. (NASDAQ:RGNX) on Monday said it aligned with the Food and Drug Administration (FDA) regarding the next steps needed for a potential accelerated approval of Navsunli (RGX-121, clemidsogene lanparvovec). The potential one-time gene therapy is seeking...
by Vandana Singh | Jun 22, 2026 | General
Read Also: AbbVie Says Nine-Year Data Reinforces Venetoclax Benefit In Leukemia Patients Biopharmaceutical giant AbbVie Inc. (NYSE:ABBV) announced Monday that it has agreed to acquire Apogee Therapeutics Inc. (NASDAQ:APGE) in a cash deal valued at approximately $10.9...
by Henry Khederian | Jun 22, 2026 | General
SoFi Technologies Inc. (NASDAQ:SOFI) shares are trading marginally lower during Monday’s premarket session as traders weigh a still-choppy longer-term downtrend against ongoing insider buying and the company’s crypto-adjacent product narrative. SoFi Technologies stock...
Recent Comments